18 Jun 2025

College of Pharmaceutical Sciences and Drug Manufacturing

4th International Conference of Pharmaceutical Sciences

The College of Pharmaceutical Sciences and Drug Manufacturing at MUST is proud to present the 4th International Conference of Pharmaceutical Sciences (ICPS4), under the theme ‘Tailored Therapy and Digital Transformation: A New Era of Interdisciplinary Healthcare. Scheduled for September 27th-28th, 2025, this landmark event will convene leading researchers, industry pioneers, and healthcare innovators to explore the interdisciplinary power of precision medicine, AI-driven drug discovery, and digital health technologies.

ICPS4 will serve as a dynamic platform for knowledge exchange, collaborative partnerships, and forward-thinking discussions. Complying with Egypt’s Vision 2030, ICPS4 hosts a milieu of sessions that conform to a quality of life:

(goal 1), justice and inclusion

(Goal 2), powerful economy

(Goal 3), knowledge and innovation

(Goal 4), environmental sustainability

(Goal 5), leading position

(Goal 8). By integrating cutting-edge science with real-world applications

The conference aims to accelerate the adoption of personalised therapies and digital innovations, governed by ethical regulations, ultimately shaping a more efficient and patient-centric future for global healthcare.

Scope

Digital therapeutics and smart drug delivery technologies.
Implications of pharmacogenomics in modern pharmacy.
Role of artificial intelligence in shaping the future of healthcare.
Highlighting the pharmacoeconomics of tailored medicine.
Ethical and regulatory considerations of tailored medicine.

Sessions

Shaping the future of precision medicine with interdisciplinary insights. (SDG2, SDG3, SDG12, SDG17)
Digital innovation enhances personalised medicine. (SDG3, SDG4, SDG9)
Pharmacoeconomic outcomes of precision medicine. (SDG3, SDG8, SDG10, SDG12)
Ethical, legal, and social issues in personalised medicine. (SDG3, SDG4, SDG5)